Budigalimab [2098225-93-3]

MedChem Express

Budigalimab [2098225-93-3]

10

2098225-93-3

Research Use Only

Monoclonal

99.79

Budigalimab (ABBV 181; PR 1648817) is a humanized, recombinant IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab has an Fc mutation that reduces the inhibition of Fc receptor interactions and effector factors. Budigalimab can block the binding of PD-1 and PD-L1, which has anti-tumor activity. Budigalimab can be used in the study of solid tumors[1].

-80°C

41116161